NCT05322356 Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System Status ACTIVE_NOT_RECRUITING Phase NA
NCT05319145 PeRsonalizing the Approach to the Oncologic Frail Individual Through Tailored Assessment and Intervention (PROFIT Study) Status UNKNOWN Phase NA
NCT05313815 Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer Status RECRUITING Phase NA
NCT05313191 Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors Status RECRUITING Phase NA
NCT05311618 Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05306600 Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System Status RECRUITING Phase N/A
NCT05304169 Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. Status COMPLETED Phase PHASE4
NCT05301114 Social Risk Factors and Discrimination in Cancer Survivorship Status ACTIVE_NOT_RECRUITING Phase NA
NCT05297162 PSMA PET/CT vs. mpMRI in Patients With a High Suspicion of Prostate Cancer: a Head to Head, Parallel, Prospective Trial Status UNKNOWN Phase NA
NCT05295407 Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy Status RECRUITING Phase N/A
NCT05294627 Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population Status COMPLETED Phase N/A
NCT05286840 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer Status UNKNOWN Phase PHASE1/PHASE2
NCT05285319 Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer Status UNKNOWN Phase PHASE2
NCT05279287 Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS) Status RECRUITING Phase N/A
NCT05276492 Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. Status TERMINATED Phase PHASE1
NCT05269550 PSMA MRI Guided Prostate SBRT (ARGOS)/Comprehensive, Longitudinal Evaluation of Imaging Biomarkers Post Radiotherapy (CLIMBER) Status ACTIVE_NOT_RECRUITING Phase NA
NCT05262608 The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation Status UNKNOWN Phase PHASE2